Cite

HARVARD Citation

    Madera, J. et al. (2020). 155 Symptom Stability in de Novo and Rollover Patients with Bipolar I Disorder Receiving Aripiprazole Once-monthly in a 52-Week, Open-label Study. CNS spectrums. p. 299. [Online]. 
  
Back to record